San Diego, CA, United States of America

Susan Yoshiko Tamura


Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 87(Granted Patents)


Company Filing History:


Years Active: 1996-2003

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Susan Yoshiko Tamura: Innovator in Enzyme Inhibition

Introduction

Susan Yoshiko Tamura is a prominent inventor based in San Diego, California. She has made significant contributions to the field of enzyme inhibitors, holding a total of 12 patents. Her work focuses on developing novel therapeutic agents that target specific enzymes involved in various disease states.

Latest Patents

Among her latest patents is one titled "Aromatic heterocyclic derivatives as enzyme inhibitors." This invention discloses peptide aldehydes that serve as potent and specific inhibitors of thrombin. These compounds, along with their pharmaceutically acceptable salts and compositions, are designed for therapeutic use in mammals suffering from abnormal thrombosis. Another notable patent is titled "Inhibitors of urokinase," which presents novel inhibitors that contain an arginine or arginine mimic aldehyde or an arginine ketoamide group at P1. These compounds are valuable for monitoring plasminogen activator levels in vitro and for treating conditions that benefit from the inhibition of urokinase activity.

Career Highlights

Susan has built a successful career at Corvas International, Inc., where she continues to innovate in the field of enzyme inhibition. Her research has led to advancements that have the potential to improve treatment options for various medical conditions.

Collaborations

Throughout her career, Susan has collaborated with notable colleagues, including William Charles Ripka and Terence Kevin Brunck. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Susan Yoshiko Tamura is a distinguished inventor whose work in enzyme inhibitors has the potential to make a significant impact in the medical field. Her innovative patents and collaborations highlight her dedication to advancing therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…